Skip to main content
. Author manuscript; available in PMC: 2024 Mar 21.
Published in final edited form as: Travel Med Infect Dis. 2017 May 6;17:50–55. doi: 10.1016/j.tmaid.2017.05.003

Table 2.

Adherence to first antimalarial for prophylaxis of malaria.

Degree of Adherence Mefloquine n (%) (N = 2972) Chloroquine n (%) (N = 668) Doxycycline n (%) (N = 828) Atovaquone-proguanil n (%) (N = 183) Overall n (%) (N = 5026)a
Taken as prescribed 1691 (56.9) 177 (26.5) 425 (51.3) 86 (47.0) 2547 (50.7)
Taken as prescribed most of the time 291 (9.8) 66 (9.9) 110 (13.3) 25 (13.7) 518 (10.3)
Taken half the time 128 (4.3) 58 (8.7) 54 (6.5) 11 (6.0) 263 (5.2)
Rarely taken 236 (7.9) 207 (31.0) 81 (9.8) 34 (18.6) 628 (12.5)
Never taken 61 (2.1) 67 (10.0) 30 (3.6) 10 (5.5) 208 (4.1)
Stopped then switched because of side effects 365 (12.3) 23 (3.4) 64 (7.7) 9 (4.9) 473 (9.4)
Other 200 (6.7) 70 (10.5) 64 (7.7) 8 (4.4) 389 (7.7)
a

“Overall” includes those who reported taking any of the four antimalarials of interest or other antimalarial, and provided information on degree of adherence.